Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $123,371.00 |
|---|---|
| Enterprise Value | $577,197.00 |
| Earnings per Share | $0 |
| Beta | 0.2 |
| Outstanding Shares | 1,233,713,103 |
| P/E Ratio | 28.74 |
|---|---|
| PEG | -3.17 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 0.96 |
| Enterprise Value to EBIT | -3.96 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 3.37 |
| Debt to Equity | -13.47 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United States, focuses on both the development and commercialization of pharmaceutical products. It also licenses its proprietary technology to other companies within the...